Chargement en cours...
Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program
BACKGROUND: Cutaneous adverse drug reactions (cADRs) can cause significant morbidity and distress in patients especially in the HIV infected population on antiretroviral therapy. Adverse Drug Reaction monitoring and ascertaining causality in resource limited settings still remains a challenge. This...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3535441/ https://ncbi.nlm.nih.gov/pubmed/23277506 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|